AU3878697A - Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors - Google Patents
Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictorsInfo
- Publication number
- AU3878697A AU3878697A AU38786/97A AU3878697A AU3878697A AU 3878697 A AU3878697 A AU 3878697A AU 38786/97 A AU38786/97 A AU 38786/97A AU 3878697 A AU3878697 A AU 3878697A AU 3878697 A AU3878697 A AU 3878697A
- Authority
- AU
- Australia
- Prior art keywords
- predictors
- prognosis
- abnormalities
- indicators
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2013896P | 1996-06-20 | 1996-06-20 | |
| US60020138 | 1996-06-20 | ||
| PCT/US1997/010557 WO1998001738A2 (en) | 1996-06-20 | 1997-06-19 | Identification of abnormalities in the expression of t and b cell antigen receptors as disease indicators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3878697A true AU3878697A (en) | 1998-02-02 |
Family
ID=21796965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU38786/97A Abandoned AU3878697A (en) | 1996-06-20 | 1997-06-19 | Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU3878697A (en) |
| WO (1) | WO1998001738A2 (en) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9710820D0 (en) * | 1997-05-27 | 1997-07-23 | Univ Dundee | Immunological method |
| WO2004024069A2 (en) * | 2002-09-11 | 2004-03-25 | Genentech, Inc. | Novel compositions and methods for the treatment of immune-related diseases |
| JP4643445B2 (en) | 2002-11-12 | 2011-03-02 | ベクトン，ディッキンソン アンド カンパニー | Diagnosis of sepsis or SIRS using biomarker profiles |
| CA2505843A1 (en) | 2002-11-12 | 2004-05-27 | Becton, Dickinson And Company | Diagnosis of sepsis or sirs using biomarker profiles |
| KR20080006617A (en) | 2005-04-15 | 2008-01-16 | 백톤 디킨슨 앤드 컴퍼니 | Diagnosis of sepsis |
| US8669113B2 (en) | 2008-04-03 | 2014-03-11 | Becton, Dickinson And Company | Advanced detection of sepsis |
| US9528160B2 (en) | 2008-11-07 | 2016-12-27 | Adaptive Biotechnolgies Corp. | Rare clonotypes and uses thereof |
| US8691510B2 (en) | 2008-11-07 | 2014-04-08 | Sequenta, Inc. | Sequence analysis of complex amplicons |
| US9506119B2 (en) | 2008-11-07 | 2016-11-29 | Adaptive Biotechnologies Corp. | Method of sequence determination using sequence tags |
| US8628927B2 (en) | 2008-11-07 | 2014-01-14 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
| US8748103B2 (en) | 2008-11-07 | 2014-06-10 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
| SG195652A1 (en) | 2008-11-07 | 2013-12-30 | Sequenta Inc | Methods of monitoring conditions by sequence analysis |
| US9365901B2 (en) | 2008-11-07 | 2016-06-14 | Adaptive Biotechnologies Corp. | Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia |
| DK3059337T3 (en) | 2009-01-15 | 2019-07-22 | Adaptive Biotechnologies Corp | Adaptive immunity profiling and methods for producing monoclonal antibodies |
| JP2012531202A (en) | 2009-06-25 | 2012-12-10 | フレッド ハチンソン キャンサー リサーチ センター | How to measure adaptive immunity |
| US9043160B1 (en) | 2009-11-09 | 2015-05-26 | Sequenta, Inc. | Method of determining clonotypes and clonotype profiles |
| US10385475B2 (en) | 2011-09-12 | 2019-08-20 | Adaptive Biotechnologies Corp. | Random array sequencing of low-complexity libraries |
| CA2853088C (en) | 2011-10-21 | 2018-03-13 | Adaptive Biotechnologies Corporation | Quantification of adaptive immune cell genomes in a complex mixture of cells |
| ES2867924T3 (en) | 2011-12-09 | 2021-10-21 | Adaptive Biotechnologies Corp | Diagnosis of Lymphoid Malignant Tumors and Detection of Minimal Residual Disease |
| US9499865B2 (en) | 2011-12-13 | 2016-11-22 | Adaptive Biotechnologies Corp. | Detection and measurement of tissue-infiltrating lymphocytes |
| EP2823060B1 (en) | 2012-03-05 | 2018-02-14 | Adaptive Biotechnologies Corporation | Determining paired immune receptor chains from frequency matched subunits |
| EP2831276B1 (en) | 2012-05-08 | 2016-04-20 | Adaptive Biotechnologies Corporation | Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions |
| US20160002731A1 (en) | 2012-10-01 | 2016-01-07 | Adaptive Biotechnologies Corporation | Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization |
| US10150996B2 (en) | 2012-10-19 | 2018-12-11 | Adaptive Biotechnologies Corp. | Quantification of adaptive immune cell genomes in a complex mixture of cells |
| US9708657B2 (en) | 2013-07-01 | 2017-07-18 | Adaptive Biotechnologies Corp. | Method for generating clonotype profiles using sequence tags |
| CA2941612A1 (en) | 2014-03-05 | 2015-09-11 | Adaptive Biotechnologies Corporation | Methods using randomer-containing synthetic molecules |
| US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
| US10392663B2 (en) | 2014-10-29 | 2019-08-27 | Adaptive Biotechnologies Corp. | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples |
| US10246701B2 (en) | 2014-11-14 | 2019-04-02 | Adaptive Biotechnologies Corp. | Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture |
| US11066705B2 (en) | 2014-11-25 | 2021-07-20 | Adaptive Biotechnologies Corporation | Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing |
| CA2976580A1 (en) | 2015-02-24 | 2016-09-01 | Adaptive Biotechnologies Corp. | Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing |
| US11041202B2 (en) | 2015-04-01 | 2021-06-22 | Adaptive Biotechnologies Corporation | Method of identifying human compatible T cell receptors specific for an antigenic target |
| US10428325B1 (en) | 2016-09-21 | 2019-10-01 | Adaptive Biotechnologies Corporation | Identification of antigen-specific B cell receptors |
| US11254980B1 (en) | 2017-11-29 | 2022-02-22 | Adaptive Biotechnologies Corporation | Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements |
| CN112301099A (en) * | 2020-11-30 | 2021-02-02 | 南方科技大学 | Primer group for amplifying B lymphocyte immune repertoire and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4886743A (en) * | 1985-04-24 | 1989-12-12 | California Institute Of Technology | Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof |
-
1997
- 1997-06-19 AU AU38786/97A patent/AU3878697A/en not_active Abandoned
- 1997-06-19 WO PCT/US1997/010557 patent/WO1998001738A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998001738A3 (en) | 1998-04-30 |
| WO1998001738A2 (en) | 1998-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3878697A (en) | Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors | |
| AU2815900A (en) | Clinical and diagnostic database | |
| AU3501197A (en) | Human stem cell antigens, dna coding therefor and their use | |
| ZA9810130B (en) | Tumor-specific antigens methods for their production and their use for imunization and diagnosis | |
| AU3143497A (en) | Methods of identifying g-coupled receptors associated with macrophage-trophic hiv, and diagnostic and therapeutic uses thereof | |
| WO1997008318A3 (en) | Compounds and methods for treatment and diagnosis of prostate cancer | |
| EP1004674A4 (en) | Human adamts-1 protein, gene coding for the same, pharmaceutical composition, and method for immunologically assaying human adamts-1 protein | |
| AU6416198A (en) | Diagnostic means useful for predictive assessment of human hepatocellular carc inoma disease (hcc), as well as diagnostic methods using the same | |
| IL110464A0 (en) | Novel proteins for the diagnosis, imaging, and therapy of human cancer | |
| AU1810899A (en) | Neuropilins and use thereof in methods for diagnosis and prognosis of cancer | |
| EP0678557A3 (en) | Blood compatible, shear sensitive gels. | |
| AUPM851694A0 (en) | New methods for diagnosis, detection of cell abnormalities and morphology of living systems | |
| AU2154297A (en) | Microparticles, process for their production, and their use in ultrasound diagnosis | |
| EP1111049A4 (en) | Novel receptor protein and method for diagnosing inflammatory diseases by using the same | |
| AU2087799A (en) | Diagnostic and therapeutic methods based upon valpha24jalphaq t cells | |
| AU1138699A (en) | Dna demethylase, therapeutic and diagnostic uses thereof | |
| AU6063900A (en) | Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses | |
| EP0774970A4 (en) | Method of using hyaluronic acid for the detection, location and diagnosis of tumors | |
| DE69800080T2 (en) | Antibodies against the prorenin profragment, reninactive substance that contains them and prorenin test that uses them | |
| GB9706395D0 (en) | Methods for clinical diagnosis | |
| EP1114860A4 (en) | Method for the diagnosis of cell proliferative disease | |
| DE69516534T2 (en) | ANTIBODIES AGAINST ALLOGENIC AND XENOGENE PROTEINS, THEIR USE IN DIAGNOSIS AND THERAPY AND METHOD FOR THE DETERMINATION THEREOF | |
| AUPO848197A0 (en) | Breast screening - early detection and aid to diagnosis | |
| AU1457300A (en) | Dna replication-regulating genes, antibodies thereto and diagnostic applicationsthereof | |
| WO1999061909A3 (en) | Methods and compositions for the detection of human herpesvirus |